期刊文献+

通心络胶囊改善小鼠糖尿病周围神经病变的保护作用 被引量:10

Protective effect of Tongxinluo capsule on diabetic peripheral neuropathy in mice
原文传递
导出
摘要 目的观察通心络胶囊对糖尿病周围神经病变小鼠的作用。方法 KK/Upj-Ay小鼠随机分为4组,模型组与高、中、低3个剂量通心络组(0.8,0.4,0.2 g·kg-1),另设C57BL/6小鼠为对照组。灌胃给药12周,测定运动神经传导速度(MNCV)和感觉神经传导速度(SNCV);实时定量荧光聚合酶链反应和蛋白质印迹法测定坐骨神经肿瘤坏死因子-α(TNF-α)、白介素-6(IL-6)、白介素-1β(IL-1β)和核因子-κB(NF-κB)表达。结果与模型组比较,通心络组的小鼠MNCV、SNCV明显增快(P<0.05,P<0.01),TNF-α、IL-6、IL-1β和NF-κB的表达显著下降(P<0.05,P<0.01)。结论通心络胶囊可抑制NF-κB通路,抑制糖尿病周围神经病变小鼠炎症因子表达,从而改善糖尿病周围神经病变。 Objective To investigate the effect of Tongxinluo capsule on diabetic peripheral neuropathy in mice .Methods KK/Upj -Ay mice were randomly divided into 4 groups,model, Tongxinluo low, middle, high doses groups (0.8, 0.4, 0.2 g· kg -1 ).C57BL/6 mice were se-lected as control group.Mice were given intragastrically for 12 weeks. Motor nerve conduction velocity ( MNCV ) and sensory nerve conduction velocity ( SNCV) were detected.The expression of tumor necrosis factor alpha ( TNF -α) , interleukin 6 ( IL -6 ) and interleukin 1 beta (IL-1β) and nuclear factor kappa B (NF-κB) in sciatic nerve were examined by real time PCR and Western blot .Results Compared with model group , MNCV and SNCV were faster ( P〈0.05 , P〈0.01 ) .The TNF-α, IL-6 , IL-1βand NF-κB expression significantly were de-creased in Tongxinluo group ( P 〈 0.05 , P 〈 0.01 ) . Conclusion Tongxinluo capsule inhibits inflammatory cytokines expres-sion in diabetic peripheral neuropathy mice by inhibiting NF -κB pathway , to ameliorates diabetic peripheral neuropathy .
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2015年第10期874-877,共4页 The Chinese Journal of Clinical Pharmacology
基金 "十二五"重大新药创制科技重大专项基金资助项目(2011ZX09101-004-02) 河北省中医药管理局科研计划基金资助项目(2014155)
关键词 通心络胶囊 糖尿病周围神经病变 炎症因子 NF-ΚB通路 Tongxinluo capsule diabetic peripheral neuropathy inflammatory cytokines nuclear factor kappa B pathway
  • 相关文献

参考文献3

二级参考文献25

  • 1相爱霞,陈成华,董砚虎.糖尿病神经病变研究进展[J].国外医学(内分泌学分册),2004,24(6):424-425. 被引量:9
  • 2蒋雨平 陆费汉倩 郑白蒂 等.糖尿病性多发性周围神经病的WHO PNTF诊断标准和10年随访[J].上海医科大学学报,1993,20:9-13. 被引量:2
  • 3吴以岭.络病学.北京:中国科学技术出版社,2002,4:65-247. 被引量:1
  • 4中药新药临床研究指导原则(试行).北京:中国医药科技出版社,2002:115~117. 被引量:36
  • 5E 1-Mesallamy H O, Hamdy N M, Ezzat O A, et al. Levels of soluble advanced glycation end product- receptors and other soluble serum markers as indicators of diabetic neuropathy in the foot[ J]. J Investig Med, 2011, 59(8) :1233. 被引量:1
  • 6Monnier V M, Vishwanath V, Frank K E, et al. Relation between complications of type I diabetes mellitus and collagen-linked fluorescence [ J ]. N Engl J Med, 1986, 314(7):403. 被引量:1
  • 7Iwai M, Kanno H, Tomono Y, et al. Direct renin inhibition improved insulin resistance and adipose tissue dysfunction in type 2 diabetic KK-A ( y ) mice [ J ]. J Hypertens, 2010, 28(7) :1471. 被引量:1
  • 8Miranda Massari J R, Gonzalez M J, Jimenez F J, et al. Metabolic correction in the management of diabetic peripheral ncuropathy: improving clinical results beyond symptom control [ J]. Curt Clin Pharmacol, 2011, 6 ( 4 ) :260. 被引量:1
  • 9Berghs S, Aggujaro D, Dirkx R J, et al. beta IV spectrin, a new speetrin localized at axon initial segments and nodes of ranvier in the central and peripheral nervous system[ J]. J Cell Biol, 2000, 151 (5) :985. 被引量:1
  • 10Karachalias N, Babaei-Jadidi R, Ahmed N, et al. Accumulation of fruetosyl-lysine and advanced glyeation end products in the kidney, retina and peripheral nerve of streptozotocin-indueed diabetic rats[ J]. Biochem Soc Trans, 2003, 31 (6) :1423. 被引量:1

共引文献201

同被引文献70

  • 1王杨,刘畅.依帕司他治疗糖尿病周围神经病变的疗效及机制[J].中国老年学杂志,2015,35(1):93-95. 被引量:77
  • 2严灿荣,梁轩伟,冯晓津,郑彪.兔眼急性高眼压对视神经血栓素A_2和前列环素的影响[J].第二军医大学学报,2005,26(7):820-821. 被引量:1
  • 3张玉波,伍亚民,刘磊,宋川,龙在云.NGF促再生周围神经中血管生成及其机制研究[J].脑与神经疾病杂志,2007,15(6):401-404. 被引量:12
  • 4Sytze Van Dam P, Cotter M A, Bravenboer B, et al. Patho- genesis of diabetic neuropathy: focus on neurovascular mecha- nisms[J]. Eur J Pharmacol, 2013, 719(1-3): 180-186. 被引量:1
  • 5Paradis A, Zhang L. Role of endothelin in uteroplacental circu- lation and fetal vascular function [ J ]. Curt Vase Pharmacol, 2013, 11(5) : 594-605. 被引量:1
  • 6Deng H, Yin J, Zhang J, et al. Meta-analysis of methylcobal- amin alone and in combination with prostaglandin E1 in the treatment of diabetic peripheral neuropathy [ J ]. Endocrine,2014, 46(3): 445-454. 被引量:1
  • 7Mtiller A M, Hermanns M I, Skrzynski C, et al. Expression of the endothelial markers PECAM-1, VWF, and CD34 in vivo and in vitro[J]. Exp Mol Pathol, 2002, 72(3) : 221-229. 被引量:1
  • 8Dooley D C, Oppenlander B K, Xiao M. Analysis of primitive CD34+ and CD34 + hematopoietic cells from adults: gain and loss of CD34 antigen by undifferentiated ceils are closely linked to proliferative status in culture [ J ]. Stem Cells, 2004, 22 (4) : 556-569. 被引量:1
  • 9Dfaz-Flores L, Guti6rrez R, Garcia M P, et al. CD34+ stro- real cells/fibroblasts/fibrocytes/telocytes as a tissue reserve and a principal source of mesenchymal cells. Location, morphology,function and role in pathology [ J ]. Ititol Histopathol, 2014, 29(7):831-870. 被引量:1
  • 10Lenting PJi Casari C, ChristopheO D al. yon Willebrand factor: the old, the new and the nown [ J]. J Thromb Hae- most, 2012, 10(12): 248-2437. 被引量:1

引证文献10

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部